These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23219427)

  • 1. Human leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.
    Wastowski IJ; Simões RT; Yaghi L; Donadi EA; Pancoto JT; Poras I; Lechapt-Zalcman E; Bernaudin M; Valable S; Carlotti CG; Flajollet S; Jensen SS; Ferrone S; Carosella ED; Kristensen BW; Moreau P
    Am J Pathol; 2013 Feb; 182(2):540-52. PubMed ID: 23219427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.
    Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS
    Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2.
    Yaghi L; Poras I; Simoes RT; Donadi EA; Tost J; Daunay A; de Almeida BS; Carosella ED; Moreau P
    Oncotarget; 2016 Sep; 7(39):63690-63707. PubMed ID: 27577073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-G Expression in Human Mesenchymal Stem Cells (MSCs) Is Related to Unique Methylation Pattern in the Proximal Promoter as well as Gene Body DNA.
    Yen BL; Hwa HL; Hsu PJ; Chen PM; Wang LT; Jiang SS; Liu KJ; Sytwu HK; Yen ML
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy.
    Shraibman B; Kadosh DM; Barnea E; Admon A
    Mol Cell Proteomics; 2016 Sep; 15(9):3058-70. PubMed ID: 27412690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-γ Stimulation and Inhibition of DNA Methylation.
    Jørgensen N; Sayed A; Jeppesen HB; Persson G; Weisdorf I; Funck T; Hviid TVF
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
    Yan WH; Lin AF; Chang CC; Ferrone S
    Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells.
    Haque A; Das A; Hajiaghamohseni LM; Younger A; Banik NL; Ray SK
    Cancer Immunol Immunother; 2007 May; 56(5):615-25. PubMed ID: 16947022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple in vitro generation of human leukocyte antigen-G-expressing T-regulatory cells through pharmacological hypomethylation for adoptive cellular immunotherapy against graft-versus-host disease.
    Stamou P; Marioli D; Patmanidi AL; Sgourou A; Vittoraki A; Theofani E; Pierides C; Taraviras S; Costeas PA; Spyridonidis A
    Cytotherapy; 2017 Apr; 19(4):521-530. PubMed ID: 28162915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines.
    Kadowaki M; Yoshioka H; Kamitani H; Watanabe T; Wade PA; Eling TE
    Int J Cancer; 2012 Jan; 130(2):267-77. PubMed ID: 21437897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
    Fonsatti E; Nicolay HJ; Sigalotti L; Calabrò L; Pezzani L; Colizzi F; Altomonte M; Guidoboni M; Marincola FM; Maio M
    Clin Cancer Res; 2007 Jun; 13(11):3333-8. PubMed ID: 17545540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.
    Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M
    J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.
    Nie Y; Yang G; Song Y; Zhao X; So C; Liao J; Wang LD; Yang CS
    Carcinogenesis; 2001 Oct; 22(10):1615-23. PubMed ID: 11577000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of DNA methylation enhances HLA-G expression in human mesenchymal stem cells.
    Teklemariam T; Purandare B; Zhao L; Hantash BM
    Biochem Biophys Res Commun; 2014 Sep; 452(3):753-9. PubMed ID: 25204503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAGED4 expression in glioma and upregulation in glioma cell lines with 5-aza-2'-deoxycytidine treatment.
    Zhang QM; Shen N; Xie S; Bi SQ; Luo B; Lin YD; Fu J; Zhou SF; Luo GR; Xie XX; Xiao SW
    Asian Pac J Cancer Prev; 2014; 15(8):3495-501. PubMed ID: 24870746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients.
    Polakova K; Bandzuchova E; Sabty FA; Mistrik M; Demitrovicova L; Russ G
    Neoplasma; 2009; 56(6):514-20. PubMed ID: 19728760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy.
    Hambach L; Ling KW; Pool J; Aghai Z; Blokland E; Tanke HJ; Bruijn JA; Halfwerk H; van Boven H; Wieles B; Goulmy E
    Blood; 2009 Mar; 113(12):2715-22. PubMed ID: 19096014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
    Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
    Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
    Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines.
    Poláková K; Bandzuchová E; Kuba D; Russ G
    Leuk Res; 2009 Apr; 33(4):518-24. PubMed ID: 18823661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.